Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development

CJ Paddon, JD Keasling - Nature reviews microbiology, 2014 - nature.com
Recent developments in synthetic biology, combined with continued progress in systems
biology and metabolic engineering, have enabled the engineering of microorganisms to …

Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination

T Bousema, C Drakeley - Clinical microbiology reviews, 2011 - journals.asm.org
Malaria remains a major cause of morbidity and mortality in the tropics, with Plasmodium
falciparum responsible for the majority of the disease burden and P. vivax being the …

Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010

H Wang, L Dwyer-Lindgren, KT Lofgren… - The Lancet, 2012 - thelancet.com
Background Estimation of the number and rate of deaths by age and sex is a key first stage
for calculation of the burden of disease in order to constrain estimates of cause-specific …

Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies

JT Griffin, TD Hollingsworth, LC Okell… - PLoS …, 2010 - journals.plos.org
Background Over the past decade malaria intervention coverage has been scaled up across
Africa. However, it remains unclear what overall reduction in transmission is achievable …

The role of early detection and treatment in malaria elimination

J Landier, DM Parker, AM Thu, VI Carrara, KM Lwin… - Malaria journal, 2016 - Springer
Falciparum malaria persists in hard-to-reach areas or demographic groups that are missed
by conventional healthcare systems but could be reached by trained community members in …

Ongoing challenges in the management of malaria

G Kokwaro - Malaria journal, 2009 - Springer
This article gives an overview of some of the ongoing challenges that are faced in the
prevention, diagnosis and treatment of malaria. Malaria causes approximately 881,000 …

Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial

P Sawa, SA Shekalaghe, CJ Drakeley… - The Journal of …, 2013 - academic.oup.com
Background. Artemisinin-based combination therapy (ACT) reduces the potential for malaria
transmission, compared with non-ACTs. It is unclear whether this effect differs between …

Next generation technology for epidemic prevention and control: data-driven contact tracking

H Chen, B Yang, H Pei, J Liu - Ieee Access, 2018 - ieeexplore.ieee.org
Contact tracking is one of the key technologies in prevention and control of infectious
diseases. In the face of a sudden infectious disease outbreak, contact tracking systems can …

Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine

M Theisen, MM Jore, R Sauerwein - Expert review of vaccines, 2017 - Taylor & Francis
Introduction: Malaria is a devastating vector-borne disease caused by the Plasmodium
parasite, resulting in almost 0.5 million casualties per year. The parasite has a complex life …